Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 119.1 | 97.0 | 71.1 | 54.0 | 41.4 |
| Revenue growth | 22.8% | 36.4% | 31.6% | 30.4% | |
| Cost of goods sold | 38.1 | 30.0 | 18.9 | 13.4 | 8.8 |
| Gross profit | 81.1 | 67.0 | 52.2 | 40.6 | 32.6 |
| Gross margin | 68.1% | 69.1% | 73.5% | 75.2% | 78.7% |
| Sales and marketing | 52.4 | 45.0 | 30.5 | 22.5 | 17.7 |
| Research and development | 31.6 | 25.8 | 19.6 | 12.3 | 7.9 |
| General and administrative | 18.7 | 12.1 | 7.6 | 4.6 | 4.2 |
| EBITA | -20.9 | -15.3 | -5.0 | 1.7 | 2.8 |
| EBITA margin | -17.6% | -15.8% | -7.0% | 3.1% | 6.7% |
| Amortization of intangibles | 0.7 | 0.5 | 0.5 | 0.4 | |
| EBIT | -21.7 | -15.8 | -5.5 | 1.2 | 2.8 |
| EBIT margin | -18.2% | -16.3% | -7.8% | 2.3% | 6.7% |
| Pre-tax income | -22.2 | -16.6 | -5.4 | 1.2 | 2.9 |
| Income taxes | 0.8 | 0.2 | 0.1 | 0.1 | 0.1 |
| Tax rate | | | | 9.4% | 4.5% |
| Net income | -23.1 | -19.2 | -10.5 | -3.9 | -2.3 |
| Net margin | -19.4% | -19.8% | -14.7% | -7.2% | -5.4% |
| |
| Diluted EPS | ($0.94) | ($1.37) | ($3.12) | ($1.36) | ($1.03) |
| Shares outstanding (diluted) | 24.4 | 14.0 | 3.4 | 2.9 | 2.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|